BRPI0924001A2 - composição para desinfecção fotodinâmica e método de aplicação da mesma. - Google Patents

composição para desinfecção fotodinâmica e método de aplicação da mesma.

Info

Publication number
BRPI0924001A2
BRPI0924001A2 BRPI0924001A BRPI0924001A BRPI0924001A2 BR PI0924001 A2 BRPI0924001 A2 BR PI0924001A2 BR PI0924001 A BRPI0924001 A BR PI0924001A BR PI0924001 A BRPI0924001 A BR PI0924001A BR PI0924001 A2 BRPI0924001 A2 BR PI0924001A2
Authority
BR
Brazil
Prior art keywords
composition
application
photodynamic disinfection
photodynamic
disinfection
Prior art date
Application number
BRPI0924001A
Other languages
English (en)
Inventor
Cale Street
Lisa Pedigo
Nicolas Loebel
Original Assignee
Ondine Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ondine Int Ltd filed Critical Ondine Int Ltd
Publication of BRPI0924001A2 publication Critical patent/BRPI0924001A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0924001A 2009-03-16 2009-10-21 composição para desinfecção fotodinâmica e método de aplicação da mesma. BRPI0924001A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16043509P 2009-03-16 2009-03-16
PCT/US2009/061442 WO2010107454A1 (en) 2009-03-16 2009-10-21 Composition for photodynamic disinfection

Publications (1)

Publication Number Publication Date
BRPI0924001A2 true BRPI0924001A2 (pt) 2016-01-26

Family

ID=41281683

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924001A BRPI0924001A2 (pt) 2009-03-16 2009-10-21 composição para desinfecção fotodinâmica e método de aplicação da mesma.

Country Status (8)

Country Link
EP (1) EP2408478B1 (pt)
JP (1) JP2012520876A (pt)
KR (1) KR20110133032A (pt)
CN (1) CN102348467B (pt)
BR (1) BRPI0924001A2 (pt)
CA (1) CA2754982C (pt)
IL (1) IL215154A0 (pt)
WO (1) WO2010107454A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011007742B3 (de) * 2011-04-20 2012-07-26 Cumdente GmbH Desinfektionseinrichtung und Desinfektionsmittel
WO2016031875A1 (ja) * 2014-08-27 2016-03-03 富士フイルム株式会社 光線力学療法用組成物、殺菌方法、殺菌システムおよび殺菌システムの作動方法
KR101622544B1 (ko) * 2014-09-29 2016-05-20 (주)나노팜 광역학 치료용 나노 이온 복합체를 포함하는 조성물 및 광역학 치료용 나노 이온 복합체를 포함하는 조성물의 제조방법
CN104304408A (zh) * 2014-11-17 2015-01-28 中国海洋大学 光动力冷杀菌保鲜方法
CN104522058A (zh) * 2014-12-18 2015-04-22 安徽大学 一种含有藻胆蛋白的光敏杀菌剂及其制备方法及其杀菌的用途
CN105617421A (zh) * 2016-01-07 2016-06-01 福建农林大学 一种保鲜膜上单增李斯特菌的灭活方法
KR102203314B1 (ko) * 2016-02-04 2021-01-15 코우지 오가사와라 광선역학 요법용 조성물, 치료 방법, 살균 시스템 및 살균 시스템의 작동 방법
US12077827B2 (en) * 2017-09-29 2024-09-03 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for predicting the risk of developing pulmonary colonization/infection by Pseudomonas aeruginosa
WO2019094502A1 (en) 2017-11-07 2019-05-16 Prescient Surgical, Inc. Methods and apparatus for prevention of surgical site infection
CN115399328B (zh) * 2021-05-27 2024-03-22 中国科学院化学研究所 一种多糖基杀菌材料及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
EP1933941A2 (en) * 2005-08-25 2008-06-25 Philip R. Houle Treatment systems for delivery of sensitizer solutions
US20100010086A1 (en) * 2006-08-04 2010-01-14 Ash Stephen R Antimicrobial therapy for indwelling catheters and for sanitizing surfaces
WO2008109424A1 (en) * 2007-03-08 2008-09-12 Ondine International Ltd. Composition, therapy and device for treatment of nail infections
US20090035725A1 (en) * 2007-08-02 2009-02-05 Ondine International, Ltd. Photodisinfection of oral cavity
US8389583B2 (en) * 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use

Also Published As

Publication number Publication date
CN102348467A (zh) 2012-02-08
KR20110133032A (ko) 2011-12-09
EP2408478A1 (en) 2012-01-25
CN102348467B (zh) 2014-02-19
WO2010107454A1 (en) 2010-09-23
JP2012520876A (ja) 2012-09-10
CA2754982C (en) 2016-06-14
CA2754982A1 (en) 2010-09-23
IL215154A0 (en) 2011-12-29
HK1165998A1 (en) 2012-10-19
EP2408478B1 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
BRPI0924001A2 (pt) composição para desinfecção fotodinâmica e método de aplicação da mesma.
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BR112012028514A2 (pt) composição para o tratamento da água residual e processo para o tratamento de água residual
PT2350096T (pt) Métodos de tratamento da encefalopatia hepática
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
PL2601979T3 (pl) Sposób sterylizacji
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
BRPI0906391A2 (pt) Máscara higiênica para proteção de outros
BR112012003372A2 (pt) vitamina d3 e análogos da mesma para o tratamento de alopecia.
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0924528A2 (pt) gerador de radionuclídeo e método para esterilização.
BRPI0924838A2 (pt) "etiqueta de sementes e método para fabricação da mesma"
BRPI0920862A2 (pt) composição, método para fabricação da mesma, e uso da mesma
BR112013009566A2 (pt) etiqueta, e, método de fabricação da mesma

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]